Pure Global

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy - Trial NCT06346340

Access comprehensive clinical trial information for NCT06346340 through Pure Global AI's free database. This Phase 4 trial is sponsored by Bausch & Lomb Incorporated and is currently Recruitment Completed. The study focuses on Dry Eye. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06346340
Phase 4
Recruitment Completed
drug
Trial Details
ClinicalTrials.gov • NCT06346340
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy

Study Focus

Dry Eye

Miebo

Interventional

drug

Sponsor & Location

Bausch & Lomb Incorporated

Laguna Hills,Petaluma,Largo,Saint Louis,Somersworth, United States of America

Timeline & Enrollment

Phase 4

Mar 11, 2024

Sep 01, 2024

100 participants

Primary Outcome

Mean difference between absolute deviations from predicted refractive error in the study eye.

Summary

A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative
 Biometry/ Keratometry and Postoperative Refractive Accuracy

ICD-10 Classifications

Ocular pain
Avulsion of eye
Other corneal deformities
Corneal ulcer
Dry mouth, unspecified

Data Source

ClinicalTrials.gov

NCT06346340

Non-Device Trial